Citadel Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.2M | Buy |
|
|||||
|
2025
Q2 | $1.42M | Sell |
|
|||||
|
2025
Q1 | $9.77M | Sell |
|
|||||
|
2024
Q4 | $41.9M | Buy |
|
|||||
|
2024
Q3 | $27.4M | Sell |
|
|||||
|
2024
Q2 | $60.6M | Sell |
|
|||||
|
2024
Q1 | $91.3M | Buy |
|
|||||
|
2023
Q4 | $86.7M | Sell |
|
|||||
|
2023
Q3 | $90.6M | Buy |
|
|||||
|
2023
Q2 | $32.6M | Buy |
|
|||||
|
2023
Q1 | $12.3M | Sell |
|
|||||
|
2022
Q4 | $28.1M | Sell |
|
|||||
|
2022
Q3 | $23.7M | Buy |
|
|||||
|
2022
Q2 | $17.3M | Buy |
|
|||||
|
2022
Q1 | $9.81M | Sell |
|
|||||
|
2021
Q4 | $11.6M | Buy |
|
|||||
|
2021
Q3 | $10.2M | Sell |
|
|||||
|
2021
Q2 | $38.4M | Buy |
|
|||||
|
2021
Q1 | $23.2M | Sell |
|
|||||
|
2020
Q4 | $59M | Buy |
|
|||||
|
2020
Q3 | $16.5M | Sell |
|
|||||
|
2020
Q2 | $37.6M | Sell |
|
|||||
|
2020
Q1 | $44.9M | Buy |
|
|||||
|
2019
Q4 | $59.7M | Buy |
|
|||||
|
2019
Q3 | $2.51M | Buy |
|
|||||
|
2019
Q2 | $1.07M | Buy |
|
|||||
|
2019
Q1 | $474K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $50K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $104K | Buy |
|